(Q35466455)

English

Pamidronate.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Pamidronate. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

M J Kellihan

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

P D Mangino

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 October 1992

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1262-1269

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Primary hyperparathyroidism: changes in the pattern of clinical presentation

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Incidence and pathophysiology of hypercalcemia

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Structure-activity relationships of various bisphosphonates

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD), in rats and mice

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Fast (4-h) or slow (24-h) infusions of pamidronate disodium (aminohydroxypropylidene diphosphonate (APD)) as single shot treatment of hypercalcaemia

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

The hypercalcemia of malignancy: pathogenesis and management

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Comparison of different dose regimes of aminohydroxypropylidene-1,1-bisphosphonate (APD) in hypercalcaemia of malignancy

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Aminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions.

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Renal phosphate threshold and response to pamidronate in humoral hypercalcaemia of malignancy.

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Leukaemia and residence near electricity transmission equipment: a case-control study

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone.

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Treatment of severe hypercalcaemia with mithramycin and aminohydroxypropylidene bisphosphonate

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Use of pamidronate for multiple myeloma osteolytic lesions

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Paget's disease of bone. An update on management.

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Clinical experience with the use of two diphosphonates in the treatment of Paget's disease

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Radiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD.

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Gallium nitrate

1 reference

https://api.crossref.org/works/10.1177%2F106002809202601015

21 January 2018

Identifiers

10.1177/106002809202601015

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35466455&oldid=1976388382"